NON-H-2 HISTOCOMPATIBILITY GENES AND ENCODED ANTIGENS
NON-H-2 HISTOCOMPATIBILITY GENES AND ENCODED ANTIGENS
批准号:
3126539
负责人:
Peter Johnson Wettstein
金额:
$15.7万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-12-01 至 1991-04-30
关键词:
Retroviridae T cell receptor T lymphocyte antibody dependent killer cell cell growth regulation complementary DNA cytokine receptors gel electrophoresis gene expression genetic library genetic manipulation genetic mapping genetic promoter element genetic transcription genetically modified animals helper T lymphocyte histocompatibility antigens histocompatibility gene immune response genes immunogenetics immunoregulation laboratory mouse linkage mapping major histocompatibility complex molecular cloning molecular oncology mouse mammary tumor virus oncogenic virus plasmids simian virus 40 virus antigen virus genetics
中文摘要
组织相容性(H)抗原由定位在外部的基因编码
的主要组织相容性复合体组成了强大的
组织移植成功的障碍。 虽然家庭
非H-2H抗原在小鼠中的表达是重要的
用于研究T细胞应答调节的模型系统,
几乎不知道这些的起源和功能
抗原 这一持续的计划旨在阐明
对多种和单一H抗原的反应机制。
我们最近发现H抗原是由
逆转录病毒和肿瘤病毒的种系整合。 的
拟议的研究计划是一个多方面的方法,
了解T细胞的机制和调节
对H抗原的反应和这种反应的成员的鉴定
重要的家庭。 第一批实验旨在揭示
这是体外T细胞对
免疫显性抗原及其与T细胞反应的相关性
vivo. (1)优先呈现显性基因的潜在作用
抗原的H-2K/D分子,(2)亲和力的差异,
T细胞上的IL-2受体的数量对显性和
优势抗原,和(2)不同类别的优势抗原
将研究辅助性和细胞溶解性T细胞。 t细胞
将分析对单个H抗原的应答,以确定(1)
H-2K分子的离散区域在H抗原中的作用
表达和确定Ir基因状态,(2)影响
H抗原特异性T细胞使用的T细胞受体V基因在
抗原特异性和H-2限制性,和(3)关系
体内和体外T细胞应答机制之间的联系。
这些研究将得到克隆和
非H-2H基因的鉴定。 观察到SV40
T抗原在转基因小鼠中被视为H抗原,
通过确定不同启动子的影响来扩展,
侧翼区作为H抗原表达。 的
一种新的乳腺肿瘤病毒与突变型H
将通过克隆该逆转录病毒来确认抗原,以评估其
编码H抗原的能力 大衣与
颜色和H基因突变将扩展,以确认大衣,
颜色突变回复导致H抗原的丢失。 最后,
逆转录病毒载体将用作插入诱变剂,
克隆单个H基因;
逆转录病毒将有助于首次克隆H基因,
粘粒文库。
英文摘要
Histocompatibility (H) antigens encoded by genes mapping outside
of the major histocompatibility complex comprise a formidable
barrier to successful tissue transplantation. Although the family
of non-H-2 H antigens in the mouse has served as an important
model system for studying the regulation of the T cell response,
virtually nothing is known of the origins and functions of these
antigens. This continuing program has been aimed at elucidating
the mechanisms of responses to multiple and single H antigens.
We have recently discovered that H antigens are generated by
germline integration of retroviruses and tumor viruses. The
proposed research plan is a multi-faceted approach to
understanding the mechanisms and regulation of the T cell
response to H antigens and the identification of members of this
important family. The first experiments are aimed at revealing
the basis for the preferential, in vitro T cell response to
immunodominant antigens and its relevance to T cell responses in
vivo. Potential roles for (1) preferential presentation of dominant
antigens by H-2K/D molecules, (2) differences in affinity and
number of IL-2 receptors on T cells specific for dominant and
dominated antigens, and (2) different classes of dominant antigens
for helper and cytolytic T cells will be investigated. The T cell
response to single H antigens will be analyzed to determine (1) the
role of discrete regions of H-2K molecules in H antigen
presentation and determination of Ir gene status, (2) the effects
of T cell receptor V genes used by H antigen-specific T cells on
antigen specificity and H-2 restriction, and (3) the relationship
between the mechanisms of in vivo and in vitro T cell responses.
These studies will be complemented by the cloning and
identification of non-H-2 H genes. The observation that the SV40
T-antigen is seen as an H antigen in transgenic mice will be
extended by determining the effects of different promoters and
flanking regions on its expression as an H antigen. The
association between a new mammary tumor virus and a mutant H
antigen will be confirmed by cloning this retrovirus to assess its
ability to encode this H antigen. The relationship between coat
color and H gene mutations will be extended to confirm that coat
color mutant reversions lead to the loss of H antigens. Finally,
retroviral vectors will be employed as insertional mutagens to
inactivate a single H gene; the cloning of the integrated
retrovirus will facilitate the first cloning of an H gene from a
cosmid library.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Competitive T Lymphocyte Responses to Multiple Antigenic Challenges
-
批准号:7982435
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2010
-
负责人:Peter Johnson Wettstein
-
依托单位:
Competitive T Lymphocyte Responses to Multiple Antigenic Challenges
-
批准号:8479207
-
项目类别:
-
资助金额:$36.69万
-
财政年份:2010
-
负责人:Peter Johnson Wettstein
-
依托单位:
Competitive T Lymphocyte Responses to Multiple Antigenic Challenges
-
批准号:8110012
-
项目类别:
-
资助金额:$39.03万
-
财政年份:2010
-
负责人:Peter Johnson Wettstein
-
依托单位:
Competitive T Lymphocyte Responses to Multiple Antigenic Challenges
-
批准号:8292973
-
项目类别:
-
资助金额:$39.03万
-
财政年份:2010
-
负责人:Peter Johnson Wettstein
-
依托单位:
CORE--IMMUNOTHERAPY
-
批准号:6989974
-
项目类别:
-
资助金额:$6.47万
-
财政年份:2004
-
负责人:Peter Johnson Wettstein
-
依托单位:
NATURAL HISTORY OF BABESIOSIS
-
批准号:2887416
-
项目类别:
-
资助金额:$26.63万
-
财政年份:1997
-
负责人:Peter Johnson Wettstein
-
依托单位:
MHC-BOUND SELF-PEPTIDES IN AUTOIMMUNE DISEASE
-
批准号:2422648
-
项目类别:
-
资助金额:$44.46万
-
财政年份:1994
-
负责人:Peter Johnson Wettstein
-
依托单位:
MHC-BOUND SELF-PEPTIDES IN AUTOIMMUNE DISEASE
-
批准号:2793778
-
项目类别:
-
资助金额:$28.35万
-
财政年份:1994
-
负责人:Peter Johnson Wettstein
-
依托单位:
MHC-BOUND SELF-PEPTIDES IN AUTOIMMUNE DISEASE
-
批准号:2551117
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1994
-
负责人:Peter Johnson Wettstein
-
依托单位:
MHC-BOUND SELF-PEPTIDES IN AUTOIMMUNE DISEASE
-
批准号:2296039
-
项目类别:
-
资助金额:$41.55万
-
财政年份:1994
-
负责人:Peter Johnson Wettstein
-
依托单位:
MHC-BOUND SELF-PEPTIDES IN AUTOIMMUNE DISEASE
-
批准号:2296040
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1994
-
负责人:Peter Johnson Wettstein
-
依托单位:
MHC-BOUND SELF-PEPTIDES IN AUTOIMMUNE DISEASE
-
批准号:2296041
-
项目类别:
-
资助金额:$42.98万
-
财政年份:1994
-
负责人:Peter Johnson Wettstein
-
依托单位:
MHC-BOUND SELF-PEPTIDES IN AUTOIMMUNE DISEASE
-
批准号:2296038
-
项目类别:
-
资助金额:$40.12万
-
财政年份:1994
-
负责人:Peter Johnson Wettstein
-
依托单位:
NON-H-2 HISTOCOMPLATIBILITY GENE AND ENCODED ANTIGENS
-
批准号:3126543
-
项目类别:
-
资助金额:$7.17万
-
财政年份:1991
-
负责人:Peter Johnson Wettstein
-
依托单位:
NON-H-2 HISTOCOMPATIBILITY GENES AND ENCODED ANTIGENS
-
批准号:3126540
-
项目类别:
-
资助金额:$19.73万
-
财政年份:1989
-
负责人:Peter Johnson Wettstein
-
依托单位:
NON-H-2 HISTOCOMPATIBILITY GENES AND ENCODED ANTIGENS
-
批准号:6532660
-
项目类别:
-
资助金额:$32.63万
-
财政年份:1989
-
负责人:Peter Johnson Wettstein
-
依托单位:
NON-H-2 HISTOCOMPATIBILITY GENES AND ENCODED ANTIGENS
-
批准号:2060326
-
项目类别:
-
资助金额:$28.04万
-
财政年份:1989
-
负责人:Peter Johnson Wettstein
-
依托单位:
NON-H-2 HISTOCOMPATIBILITY GENES AND ENCODED ANTIGENS
-
批准号:6169383
-
项目类别:
-
资助金额:$30.76万
-
财政年份:1989
-
负责人:Peter Johnson Wettstein
-
依托单位:
NON-H-2 HISTOCOMPATIBILITY GENES AND ENCODED ANTIGENS
-
批准号:2060327
-
项目类别:
-
资助金额:$26.79万
-
财政年份:1989
-
负责人:Peter Johnson Wettstein
-
依托单位:
NON-H-2 HISTOCOMPATIBILITY GENES AND ENCODED ANTIGENS
-
批准号:3126542
-
项目类别:
-
资助金额:$17.29万
-
财政年份:1989
-
负责人:Peter Johnson Wettstein
-
依托单位:
海外基金